Data provided by Nasdaq. Minimum 15 minutes delayed.
February 20, 2017
NantHealth to Showcase New Oncology Solution Suite, Advanced Medication Adherance Solution and the Latest in Device Connectivity at HIMSS 2017 Annual Conference
Products transform the way critical diseases like cancer are known and treated NantHealth to exhibit in booth #5561 and provide live demos on the Interoperability Showcase™ Floor ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 20, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today that it will be exhibiting its new suite of oncology solutions at booth #5561 and provi...
December 19, 2016
NantHealth to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 9
CULVER CITY, Calif.--(BUSINESS WIRE)--Dec. 19, 2016-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that the company will present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017, at 5 p.m. Pacific Standard Time at the Westin St. Francis Hotel in San Francisco. An audio-only webcast of the presentation will be available at www.NantHealth.com. ...
December 16, 2016
NantHealth, Inc. Announces Pricing of $100 Million of 5.50% Convertible Notes
CULVER CITY, Calif.--(BUSINESS WIRE)--Dec. 16, 2016-- NantHealth, Inc. (Nasdaq: NH) today announced the pricing of an aggregate of $100 million principal amount of 5.50% Convertible Senior Notes due 2021 (the "Notes"), in a private offering to qualified institutional buyers pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended (the "Act"), and a separate concurrent private placement under Section 4(a)(2) of the Act to...
|There are currently no events scheduled.|